The U.S. blood pressure monitoring devices market size is calculated at USD 670.20 million in 2025 and is forecasted to reach around USD 1388.17 million by 2034, accelerating at a CAGR of 7.64% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Blood Pressure Monitoring Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by Product, 2025-2034
8.1.1. Digital Blood Pressure Monitor
8.1.1.1. Market Revenue and Volume Forecast (2022-2034)
8.1.2. Sphygmomanometer
8.1.2.1. Market Revenue and Volume Forecast (2022-2034)
8.1.3. Ambulatory Blood Pressure Monitor
8.1.3.1. Market Revenue and Volume Forecast (2022-2034)
8.1.4. Instruments & Accessories
8.1.4.1. Market Revenue and Volume Forecast (2022-2034)
8.1.5. Transducers
8.1.5.1. Market Revenue and Volume Forecast (2022-2034)
9.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by End User, 2025-2034
9.1.1. Ambulatory Surgical Centers & Clinics
9.1.1.1. Market Revenue and Volume Forecast (2022-2034)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Volume Forecast (2022-2034)
9.1.3. Home Healthcare
9.1.3.1. Market Revenue and Volume Forecast (2022-2034)
10.1. U.S.
10.1.1. Market Revenue and Volume Forecast, by Product (2022-2034)
10.1.2. Market Revenue and Volume Forecast, by End User (2022-2034)
11.1. Koninklijke Philips N.V.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. General Electric Company
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. SunTech Medical, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Welch Allyn
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. American Diagnostic Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Briggs Healthcare
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Spacelabs Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. GF HEALTH PRODUCTS, INC.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Rossmax International Limited
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Microlife Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client